Amgen

We only need a few more clicks to be able to show the most read stories for this topic. Take a look at the latest headlines below and help us out by clicking on what you find interesting!
In the last 7 days
Better Weight Loss Stock: Amgen or Viking Therapeutics? The Motley Fool16:05 22-May-25
HyClone Seeks to Quash Amgen’s Subpoena Issued in Amgen/Accord Denosumab BPCIA Litigation JD Supra20:05 21-May-25
Regeneron Awarded $407 Million in Amgen Antitrust Suit JD Supra18:16 20-May-25
Amgen vs Bristol Myers: Which Biotech Giant Has Better Prospects? Zacks19:40 19-May-25
Regeneron Win Underscores Importance of Simple Market Definition Bloomberg Law18:45 19-May-25
In the last month
Amgen To Present At The 2025 RBC Capital Markets Global Healthcare Conference Amgen (Press Release)21:02 16-May-25
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock Zacks15:02 16-May-25
Supporting career development in the biotech space Silicon Republic13:23 16-May-25
It's Unlikely That Amgen Inc.'s (NASDAQ:AMGN) CEO Will See A Huge Pay Rise This Year Simply Wall St13:21 16-May-25
Amgen Owes $406M for Monopolizing Cholesterol Drug Market, Jury Rules Insurance Claims Journal06:03 16-May-25
Stock Of The Day: Amgen Slips With Healthcare Sector, But Signals Point To A Reversal Benzinga20:46 15-May-25
Regeneron Wins $407 Million Verdict Against Amgen in Rebate Case Bloomberg Law20:20 15-May-25
Regeneron Prevails over Amgen in Antitrust PCSK9 Lawsuit Protecting Biotech Innovation and Patient Access to… Regeneron Pharmaceuticals (Press Release)19:04 15-May-25
US Pharma stocks Pfizer, Amgen, Merck & Co. jump over 3% on Wall Street open after Trump cut… Mint14:47 12-May-25
Amgen To Present At The Bank Of America Merrill Lynch Global Healthcare Conference PR Newswire (Press Release)21:02 9-May-25
Amgen’s Tepezza granted marketing authorisation in the UK PharmaTimes09:59 8-May-25
Amgen’s Tepezza®▼ (teprotumumab) Granted Marketing Authorisation as the First Targeted… Business Wire (Press Release)17:56 7-May-25
Donald Tump’s Aberdeen links lands DP World Tour event but no sign yet of Irish Open for Doonbeg The Irish Independent16:11 6-May-25
Is Trending Stock Amgen Inc. (AMGN) a Buy Now? Zacks15:09 5-May-25
Amgen's Better Than Expected Q1 Earnings Take Backseat As Eyes Are On MariTide Obesity Data Benzinga21:11 2-May-25
Amgen’s Stelara biosimilar gets off to fast start BioPharma Dive17:23 2-May-25
Amgen (AMGN) Tops Q1 Earnings and Revenue Estimates Zacks23:16 1-May-25
Amgen beats Q1 earnings, revenue estimates. Stock flat. Yahoo! US21:41 1-May-25
Amgen quarterly profit tops Wall Street view, sales up 11% Yahoo! US21:31 1-May-25
Beat the Nasdaq With This Cash-Gushing Dividend Stock The Motley Fool13:37 1-May-25
Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report? Zacks18:16 30-Apr-25
This biotech firm helps employees grow their careers – both across borders and disciplines The Straits Times22:10 29-Apr-25
Amgen Announces Webcast Of 2025 First Quarter Financial Results Amgen (Press Release)21:06 28-Apr-25
Amgen pours $900m into US manufacturing capacity with Ohio expansion Manufacturing Chemist13:10 28-Apr-25
Amgen Reveals $900 Million Plant Manufacturing Expansion In Ohio Pharmaceutical Online12:20 28-Apr-25
Amgen to invest $900m in Ohio manufacturing facility Pharmaceutical Technology11:54 28-Apr-25
Amgen (NasdaqGS:AMGN) Expands Ohio Facility With US$900 Million Investment Simply Wall St19:50 26-Apr-25
Pharma reshoring: Amgen invests $900M in Ohio biotech facility Yahoo! US22:17 25-Apr-25
Amgen to expand Ohio biotech manufacturing plant Yahoo! UK & Ireland18:17 25-Apr-25
Amgen Announces $900 Million Manufacturing Expansion, Creation Of 350 New Jobs In Ohio PR Newswire (Press Release)17:53 25-Apr-25

      
            
      
    view more headlines
   
      
      
      
22 May 16:05
   
Amgen

Biotech Top Stories

UK Top Stories

World Top Stories
